Dr. Mostafa Borahay, MD

• Obstetrics & Gynecology

• Gynecologic Surgery

• Laparoscopic Surgery

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Phd In Biomedical Science, University Of Texas Medical Branch

  2014

• University Of Texas Med Branch Galveston

  Residency Hospital, 2010

• University Of Texas Medical Branch Hospital

  Residency Hospital, 2010

• University Of Texas Medical Branch

  Internship Hospital, 2007

• Faculty Med Zagazig University

  Residency Hospital, 2002

• Zagazig University

  Undergraduate School, 1998

• Fac Med, Zagazig University

  Medical School, 1998

• Zagazig University, Faculty Of Medicine

  Medical School, 1998

• Initial Experience with Robotic Retropubic Urethropexy Compared to Open Retropubic Urethropexy, 2013-09-08

• Vascular Biology of Uterine Fibroids: Connecting Fibroids and Vascular Disorders, 2021-07-08

• Differential Response to Hypoxia in Leiomyoma and Myometrial Cells, 2021-12-21

• Predictors of the Cost of Hysterectomy for Benign Indications, 2020-10-09

• Simvastatin-loaded Liposome Nanoparticles Treatment for Uterine Leiomyoma in a Patient-Derived Xenograft Mouse Model: A Pilot Study, 2022-02-15

• Pelvic Pain and Apical Prolapse Surgery: A Population-Based Retrospective Cohort Study, 2019-01-11

• Liposomal 2-Methoxyestradiol Nanoparticles for Treatment of Uterine Leiomyoma in a Patient-Derived Xenograft Mouse Model, 2020-07-06

• Simvastatin inhibits stem cell proliferation in human leiomyoma via TGF-ß3 and Wnt/ß-Catenin pathways, 2022-02-04

• Simvastatin modulates estrogen signaling in uterine leiomyoma via regulating receptor palmitoylation, trafficking and degradation, 2021-08-28

• Management of the Jehovah's Witness in Obstetrics and Gynecology: A Comprehensive Medical, Ethical and Legal Approach, 2016-06-02

• Oxidative Stress and Antioxidants in Uterine Fibroids: Pathophysiology and Clinical Implications, 2023-03-26

• Predictors of New Persistent Opioid Use After Benign Hysterectomy in the United States, 2022-03-03

• Disparities in Utilization of Laparoscopic Hysterectomies: A Nationwide Analysis, 2013-09-04

• Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids, 2021-07-04

• Incidence of occult leiomyosarcoma in presumed morcellation cases: a database study, 2015-11-28

• Opioid Dispensing After Hysteroscopy in the United States, 2021-12-01

• Catechol-O-Methyltransferase Expression and 2-Methoxyestradiol Affect Microtubule Dynamics and Modify Steroid Receptor Signaling in Leiomyoma Cells, 2009-10-07

• Trends in the National Distribution of Laparoscopic Hysterectomies from 2003-2010, 2014-01-24

• Diet and Nutrition in Gynecological Disorders: A Focus on Clinical Studies, 2021-05-21

• Comparison of Perioperative Outcomes of Total Laparoscopic and Robotically Assisted Hysterectomy for Benign Pathology during Introduction of a Robotic Program, 2011-10-05

• Cardiometabolic Risk Factors and Benign Gynecologic Disorders, 2019-07-29

• Hypoxia Induces Proliferation via NOX4-Mediated Oxidative Stress and TGF-ß3 Signaling in Uterine Leiomyoma Cells, 2022-04-15

• Mullerian Inhibiting Substance Suppresses Proliferation and Induces Apoptosis and Autophagy in Endometriosis CellsIn Vitro, 2013-06-19

• Outcomes of robotic, laparoscopic, and open hysterectomy for benign conditions in obese patients, 2018-06-04

• Adipocyte and Adipokines Promote a Uterine Leiomyoma Friendly Microenvironment, 2023-01-31